Activity Report 2021: Investment Banking for a Better Future

In celebration of our 25^th Anniversary and record-breaking performance, we are excited to announce the publication of our 2021 Report, Investment Banking for a Better Future.

In a landmark year for Bryan Garnier, our revenues reached €100m, and we completed over 70 transactions throughout Europe, including 35 M&A deals with leading private equity investors and global corporations. We acted as bookrunner for more than 35 growth financings, from later stage private placements to IPOs and follow-ons, on 6 different European stock markets and on the US Nasdaq.

We promoted 11 Managing Directors across the firm and elected two new Partners to the partnership in 2021, perfectly positioning the firm to continue its long-term growth trajectory.

In 2021, approximately 85% of the €2.75bn of capital we raised for our clients, was for companies that are actively working to improve human health and to help the fight against climate change. Enabling the success of some of the most innovative companies in Europe and their investors is core to our purpose and we thank our clients who continue to choose us as their trusted long-term partner.

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.

As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.